). Goldenberg received an
"Outstanding Investigator Grant" award from the National Cancer Institute for
his work in radioimmunodetection, and in 1986 he received the New Jersey Pride
Award in Science and Technology. Such statements, including statements regarding clinical trials,
out-licensing arrangements, and capital raising activities, involve
significant risks and uncertainties and actual results could differ materially
from those expressed or implied herein. Under this expanded program, Springer will provide the
vast majority of relevant Russian scientific content, making the company the
market leader in the sector with more than 150 journals from this region.

science musical

I am
especially grateful to the Society for recognizing my contributions to basic
science applied to nuclear medicine," commented Dr.
In awarding Dr. Goldenberg
Dr.

He has written or co-authored more than
1,500 journal articles, book chapters and abstracts on cancer research,
detection and treatment, and has researched and written extensively in the
area of radioimmunodetection and radioimmunotherapy using radiolabeled
antibodies. In 1985 and again in 1992, Dr.

About Immunomedics
Immunomedics is a New Jersey-based biopharmaceutical company focused on
the development of monoclonal antibody-based products for the targeted
treatment of cancer, autoimmune and other serious diseases.S.

This release, in addition to historical information, may contain forward-
looking statements made pursuant to the Private Securities Litigation Reform
Act of 1995 . The initial result will be an
expansion of the Springer catalogue of Russian journals in English by
approximately 50 new journals, with further expansions anticipated during the
course of the agreement.

For enquiries, please contact:

Joan Robinson
Springer
Telephone: +49-(0)-6221-487-8130
joan.

social journal

Aebersold Award at the 52nd Annual Meeting of the Society of
Nuclear Medicine in Toronto, Canada. Goldenberg. David M.), and the University of Heidelberg
(Germany) School of Medicine (M.
The Russian Library of Science will contain the best articles and papers
from research institutes and scientific societies in Russia and the
surrounding countries .

science through

(Nasdaq: IMMU), a leading biopharmaceutical company focused on developing
monoclonal antibodies , announced today that its founder and Chairman of the
Board of Directors, David M. Goldenberg, Sc ., M.
Dr.D. Our lead product candidate, epratuzumab, is
currently in two pivotal Phase III trials , for the treatment of patients with
moderate and severe lupus.com

semiotics through

He also serves as Chairman of the
Board of Directors of IBC Pharmaceuticals, Inc. Goldenberg was honored as the ninth Herz
Lecturer of the Tel Aviv University Faculty of Life Sciences. Its publication spectrum includes
biomedicine and life sciences, clinical and practice-oriented medicine,
physics, technology, mathematics, geosciences , computer sciences, economics
and humanities.

linguistics bibliography

David M. Goldenberg Receives Highest Award from Society of Nuclear Medicine

S. Dr. Goldenberg the co-recipient of its 1994
Abbott Award.

Springer Expands Market Leadership in Russia Through New Journals Agreement With the Publisher of the Russian Academy of Sciences

Content From MAIK Nauka/Interperiodica to be Made Available to
Subscribers of SpringerLink

NEW YORK, HEIDELBERG, Germany and MOSCOW, Russia,
Springer and MAIK Nauka /Interperiodica announce a major expansion of the
English-language journals program of the Russian Academy of Sciences.

bibliography science

, Immunomedics, Inc. In addition to his position with Immunomedics, Dr. Goldenberg is
President of the Center for Molecular Medicine and Immunology ("CMMI"), an
independent non -profit research center, and its clinical unit, the Garden
State Cancer Center. The International Society for Oncodevelopmental
Biology and Medicine also named Dr.
Springer is one of the oldest and leading international scientific
publishing companies and ranks second in the world in the science ,
technology, and medicine sector (STM).

articles 1998

"I am humbled to be among these giants of nuclear medicine.

For More Information:
Dr. "The arrangement with MAIK Nauka will also cover the development
of new publications for the scientific information market," he added, "for
example , individual spin-offs from existing journals, and 'premium journals,'
which provide users with an electronic link between journals and handbooks on
specific topics.

sciences bibliography

Goldenberg its highest honor, the Society of Nuclear
Medicine recognized his contributions to the basic science of nuclear medicine
by his pioneering work in the development of radiolabeled antibodies for
various applications in the detection, diagnosis, and therapy of solid tumors,
such as colorectal, pancreatic, lung, breast , and ovarian cancers, as well as
certain hematologic cancers, such as lymphoma and multiple myeloma .), the University of Erlangen-Nuremberg (Germany)
Faculty of Natural Sciences (Sc. We have developed
a number of advanced proprietary technologies that allow us to create
humanized antibodies that can be used either alone in unlabeled or "naked"
form, or conjugated with radioactive isotopes, chemotherapeutics or toxins, in
each case to create highly targeted agents.
Visit the Company's web site at http: //www.com.

linguistics bibliography

Aebersold Award for Outstanding Achievement -

MORRIS PLAINS, N.

About Dr. David M. Goldenberg is the founder of Immunomedics and is currently
the Chairman of its Board of Directors.D."
SpringerLink contains over 1,200 journals.

science bibliography

D.D. In addition, he
received the 1991 Mayneord 3M Award and Lectureship of the British Institute
of Radiology, and in 2002, the Elis Bervin Lectureship and Medal from the
Swedish Medical Society and the Swedish Oncology Society for his contributions
to the development of radiolabeled monoclonal antibodies used in the imaging
and treatment of cancer. We
believe that our portfolio of intellectual property, which includes
approximately 90 issued patents in the United States, and more than 250 other
issued patents worldwide , protects its product candidates and technologies.
Starting in January, 2006, some 105 of the most important scientific
journals will be translated into English and compiled into an independent
online library within SpringerLink, the Internet portal of Springer, under
the name "Russian Library of Science".
"The new program opens the door for the worldwide scientific community to
gain access to leading Russian research literature, all with a few clicks on
SpringerLink," commented Rudiger Gebauer, Springer's President, Global
Publishing. Springer also provides an historical online
archive going back to the year 1860.

semiotics books

, a subsidiary of Immunomedics. Goldenberg is a graduate of the University of Chicago College and Division
of Biological Sciences (B. At present, there is no cure for lupus and no new
lupus treatment drug has been approved in the U.immunomedics. The journals include prestigious
publications such as JETP (Journal of Experimental and Theoretical Physics)
and Physics of the Solid State, both previously distributed by the American
Institute of Physics (AIP), as well as prominent journals such as Doklady
Mathematics, previously distributed by EBSCO. It also has 25 prominent book
series that contain, in total, approximately 2,700 volumes, handbooks,
reference works, and databases. It publishes 1,350 journals and over 3,500 new books every
year, from 13 locations around the world.robinson@springer-sbm.

articles journal

J., was the recipient of the
2005 Paul C. Using these technologies , we have
built a pipeline of therapeutic product candidates that utilize several
different mechanisms of action. Factors that could cause such
differences include, but are not limited to, risks associated with new product
development (including clinical trials outcome and regulatory
requirements/actions ), competitive risks to marketed products and availability
of financing and other sources of capital , as well as the risks discussed in
the Company's Annual Report on Form 10-K for the fiscal year ended June 30,
2004. The Company is not under any obligation, and the Company expressly
disclaims any obligation, to update or alter any forward-looking statements,
whether as a result of new information , future events or otherwise.com

through social

- 2005 Paul C. in the last 40 years. Chau Cheng
Associate Director, Investor Relations + Business Analysis,
(973)605-8200 extension 123
ccheng@immunomedics.

bibliographies sciences

---

- - kjjkjk

Loading...

(Note: These pages use the Atlas Content Safeguard System (ACSS) and require that Javascript is enabled for viewing.)